These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24977319)

  • 1. 4-nitroquinoline-1-oxide-induced mutagen sensitivity and risk of cutaneous melanoma: a case-control analysis.
    Wang LE; Li C; Xiong P; Gershenwald JE; Prieto VG; Duvic M; Lee JE; Grimm EA; Hsu TC; Wei Q
    Melanoma Res; 2016 Apr; 26(2):181-7. PubMed ID: 24977319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-Nitroquinoline-1-oxide-induced mutagen sensitivity and risk of nonmelanoma skin cancer: a case-control analysis.
    Wang LE; Hsu TC; Xiong P; Strom SS; Duvic M; Clayman GL; Weber RS; Lippman SM; Goldberg LH; Wei Q
    J Invest Dermatol; 2007 Jan; 127(1):196-205. PubMed ID: 16841033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA repair capacity correlates with mutagen sensitivity in lymphoblastoid cell lines.
    Wei Q; Spitz MR; Gu J; Cheng L; Xu X; Strom SS; Kripke ML; Hsu TC
    Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):199-204. PubMed ID: 8833620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis.
    Wang LE; Xiong P; Strom SS; Goldberg LH; Lee JE; Ross MI; Mansfield PF; Gershenwald JE; Prieto VG; Cormier JN; Duvic M; Clayman GL; Weber RS; Lippman SM; Amos CI; Spitz MR; Wei Q
    J Natl Cancer Inst; 2005 Dec; 97(24):1822-31. PubMed ID: 16368944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three measures of mutagen sensitivity in a cancer-free population.
    Gu J; Bondy ML; Sigurdson A; Spitz MR; Hsu TC; Wu X
    Cancer Genet Cytogenet; 1999 Apr; 110(1):65-9. PubMed ID: 10198626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagen sensitivity exhibits a dose-response relationship in case-control studies.
    Wu X; Hsu TC; Spitz MR
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):577-8. PubMed ID: 8827363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblasts from patients with hereditary cutaneous malignant melanoma are abnormally sensitive to the mutagenic effect of simulated sunlight and 4-nitroquinoline 1-oxide.
    Howell JN; Greene MH; Corner RC; Maher VM; McCormick JJ
    Proc Natl Acad Sci U S A; 1984 Feb; 81(4):1179-83. PubMed ID: 6422469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagen sensitivity as measured by induced chromatid breakage as a marker of cancer risk.
    Wu X; Zheng YL; Hsu TC
    Methods Mol Biol; 2014; 1105():183-92. PubMed ID: 24623229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between sensitivity of cells from patients with hereditary cutaneous malignant melanoma to killing and mutations by 4-nitroquinoline 1-oxide and adduct formation.
    Sato K; Howell JN; Greene MH; Maher VM; McCormick JJ
    Cancer Res; 1988 Sep; 48(18):5145-50. PubMed ID: 3136916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-NQO induces apoptosis via p53-dependent mitochondrial signaling pathway.
    Han H; Pan Q; Zhang B; Li J; Deng X; Lian Z; Li N
    Toxicology; 2007 Feb; 230(2-3):151-63. PubMed ID: 17169477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses of entomopathogenic fungi to the mutagen 4-nitroquinoline 1-oxide.
    Araújo CAS; Dias LP; Ferreira PC; Mittmann J; Pupin B; Brancini GTP; Braga GÚL; Rangel DEN
    Fungal Biol; 2018 Jun; 122(6):621-628. PubMed ID: 29801807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions.
    Wu X; Lippman SM; Lee JJ; Zhu Y; Wei QV; Thomas M; Hong WK; Spitz MR
    Cancer Res; 2002 May; 62(10):2813-8. PubMed ID: 12019158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagen sensitivity in common cutaneous malignant melanoma and dysplastic naevus syndrome.
    Cloos J; Willems EM; van Warmerdam JM; Braakhuis BJ; Snow GB; Meijer S
    Melanoma Res; 1999 Jun; 9(3):292-6. PubMed ID: 10465585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation spectrum of 4-nitroquinoline N-oxide in the lacI transgenic Big Blue Rat2 cell line.
    Ryu J; Youn J; Kim Y; Kwon O; Song Y; Kim H; Cho K; Chang I
    Mutat Res; 1999 Sep; 445(1):127-35. PubMed ID: 10521698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic DNA damaging effects of 4-nitroquinoline-1-oxide and non-effective concentrations of methyl methanesulfonate in human fibroblasts.
    Hömme M; Jacobi H; Juhl-Strauss U; Witte I
    Mutat Res; 2000 Nov; 461(3):211-9. PubMed ID: 11056292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 1,4-phenylenebis(methylene)selenocyanate on mutagenesis and p53 protein expression in the tongue of lacI rats treated with 4-nitroquinoline-N-oxide.
    Guttenplan J; Chen KM; Khmelnitsky M; Kosinska W; Hennessy J; Bruggeman R; Desai D; Amin S; Sun YW; Spratt TE; El-Bayoumy K
    Mutat Res; 2007 Dec; 634(1-2):146-55. PubMed ID: 17720616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A yeast homologue of the human phosphotyrosyl phosphatase activator PTPA is implicated in protection against oxidative DNA damage induced by the model carcinogen 4-nitroquinoline 1-oxide.
    Ramotar D; Belanger E; Brodeur I; Masson JY; Drobetsky EA
    J Biol Chem; 1998 Aug; 273(34):21489-96. PubMed ID: 9705277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA repair and mutagen sensitivity in patients with triple primary cancers.
    Miller DG; Tiwari R; Pathak S; Hopwood VL; Gilbert F; Hsu TC
    Cancer Epidemiol Biomarkers Prev; 1998 Apr; 7(4):321-7. PubMed ID: 9568788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 protein activates the transcription of human proliferating cell nuclear antigen in response to 4-nitroquinoline N-oxide treatment.
    Li Y; Wang L; Li S; Guo T; Guo X; Yan P; Chen Y; Wang L; Lu C
    Int J Biochem Cell Biol; 2005 Feb; 37(2):416-26. PubMed ID: 15474986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro protective effects of Terminalia arjuna bark extracts against the 4-nitroquinoline-N-oxide genotoxicity.
    Pasquini R; Scassellati-Sforzolini G; Villarini M; Moretti M; Marcarelli M; Fatigoni C; Kaur S; Kumar S; Grover IS
    J Environ Pathol Toxicol Oncol; 2002; 21(1):33-44. PubMed ID: 11934011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.